These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29967020)

  • 1. Broad-Spectrum Adaptive Antibiotic Resistance Associated with Pseudomonas aeruginosa Mucin-Dependent Surfing Motility.
    Sun E; Gill EE; Falsafi R; Yeung A; Liu S; Hancock REW
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfing Motility: a Conserved yet Diverse Adaptation among Motile Bacteria.
    Sun E; Liu S; Hancock REW
    J Bacteriol; 2018 Dec; 200(23):. PubMed ID: 30224438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug Adaptive Resistance of Pseudomonas aeruginosa Swarming Cells.
    Coleman SR; Blimkie T; Falsafi R; Hancock REW
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
    Muller C; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1211-21. PubMed ID: 21149619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
    Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58.
    Pletzer D; Sun E; Ritchie C; Wilkinson L; Liu LT; Trimble MJ; Wolfmeier H; Blimkie TM; Hancock REW
    PLoS Pathog; 2020 Mar; 16(3):e1008444. PubMed ID: 32208458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin promotes rapid surface motility in Pseudomonas aeruginosa.
    Yeung AT; Parayno A; Hancock RE
    mBio; 2012; 3(3):. PubMed ID: 22550036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa.
    Khaledi A; Schniederjans M; Pohl S; Rainer R; Bodenhofer U; Xia B; Klawonn F; Bruchmann S; Preusse M; Eckweiler D; Dötsch A; Häussler S
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4722-33. PubMed ID: 27216077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis.
    Lim CLL; Chua AQ; Teo JQM; Cai Y; Lee W; Kwa AL
    Int J Infect Dis; 2018 Nov; 76():48-57. PubMed ID: 29870795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
    Potron A; Poirel L; Nordmann P
    Int J Antimicrob Agents; 2015 Jun; 45(6):568-85. PubMed ID: 25857949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.
    Cabot G; Zamorano L; Moyà B; Juan C; Navas A; Blázquez J; Oliver A
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1767-78. PubMed ID: 26729493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Genomics Reveals a Well-Conserved Intrinsic Resistome in the Emerging Multidrug-Resistant Pathogen Cupriavidus gilardii.
    Ruiz C; McCarley A; Espejo ML; Cooper KK; Harmon DE
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31578249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.
    Skiada A; Markogiannakis A; Plachouras D; Daikos GL
    Int J Antimicrob Agents; 2011 Mar; 37(3):187-93. PubMed ID: 21295448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
    Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M
    J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the
    Sanz-García F; Alvarez-Ortega C; Olivares-Pacheco J; Blanco P; Martínez JL; Hernando-Amado S
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
    Phoon HYP; Hussin H; Hussain BM; Thong KL
    Microb Drug Resist; 2018 Oct; 24(8):1108-1116. PubMed ID: 29437541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.